🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Qiming Wang

Henan Cancer Hospital

ORCID: 0000-0003-3217-1077
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib”.

Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

Cancer Research(2021)10.1158/0008-5472.can-21-0556
N/A
0.637DataRank · unranked
69 citations

Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang +7 more

Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR Inhibitors

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0147
N/A
0.568DataRank · unranked
43 citations

Jianping Guo, Karin A. Vallega, C. Hu, Zhen Chen, Yunfu Deng +7 more

Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients

Translational research(2021)10.1016/j.trsl.2020.12.009
N/A
0.477DataRank · unranked
23 citations

Zhensheng Liu, Dongfang Tang, Hongliang Liu, Sheng Luo, Thomas E. Stinchcombe +7 more

DNA topoisomerase II inhibition potentiates osimertinib’s therapeutic efficacy in EGFR-mutant non–small cell lung cancer models

Journal of Clinical Investigation(2024)10.1172/jci172716
N/A
0DataRank · unranked
30 citations

Karin A. Vallega, Dongsheng Wang, Zihan Quan, Songqing Fan, Qiming Wang +4 more

Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer

The Journal of Experimental Medicine(2024)10.1084/jem.20240435
N/A
0DataRank · unranked
15 citations

Karin A. Vallega, Dongsheng Wang, Zihan Quan, Songqing Fan, Qiming Wang +4 more

Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer

Advanced Science(2024)10.1002/advs.202310126
N/A
0DataRank · unranked
10 citations

Karin A. Vallega, Vijay K. Boda, Zihan Quan, Dongsheng Wang, Songqing Fan +5 more

Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-02877-9
N/A
0DataRank · unranked
25 citations

Dongfang Tang, Yu Zhao, Hongliang Liu, Sheng Luo, Thomas E. Stinchcombe +7 more

Data from Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

(2023)10.1158/0008-5472.c.6513256.v1
N/A
0DataRank · unranked
0 citations

Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang +7 more